Pharming Group (PHAR) PT Lowered to $40 at Oppenheimer
Get Alerts PHAR Hot Sheet
Price: $12.24 -0.33%
Rating Summary:
2 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Rating Summary:
2 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Join SI Premium – FREE
Oppenheimer lowered its price target on Pharming Group (NASDAQ: PHAR) to $40.00 (from $41.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Goldman Sachs Upgrades Plains GP Holdings, L.P (PAGP) to Neutral
- Suntory Beverage & Food Ltd (2587:JP) (STBFY) PT Lowered to JPY4,600 at Nomura/Instinet
- Nomura/Instinet Downgrades ORIX Corp (8591:JP) (IX) to Neutral
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share